P01.01 HERTHENA-Lung01: A Randomized Phase 2 Study of Patritumab Deruxtecan (HER3-DXd; U3-1402) in Previously Treated Metastatic EGFR-mutated NSCLC

Authors :: Melissa Lynne Johnson
Yang Qiu
Sixue Chen
Yasushi Goto
Helena Alexandra Yu
S. Karam
J.C.-H. Yang
C. Yu
Pasi A. Jänne
Source :: Journal of Thoracic Oncology. 16:S236
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Patritumab
Oncology
business.industry
Cancer research
Phases of clinical research
Medicine
Previously treated
business

Full Text Access

Tools